It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mycobacterium tuberculosis (M.tb), the pathogen responsible for tuberculosis (TB) poses as the major cause of death among infectious diseases. The knowledge about the molecular diversity of M.tb enables the implementation of more effective surveillance and control measures and, nowadays, Whole Genome Sequencing (WGS) holds the potential to produce high-resolution epidemiological data in a high-throughput manner. Florianópolis, the state capital of Santa Catarina (SC) in south Brazil, shows a high TB incidence (46.0/100,000). Here we carried out a WGS-based evaluation of the M.tb strain diversity, drug-resistance and ongoing transmission in the capital metropolitan region. Resistance to isoniazid, rifampicin, streptomycin was identified respectively in 4.0% (n = 6), 2.0% (n = 3) and 1.3% (n = 2) of the 151 studied strains by WGS. Besides, resistance to pyrazinamide and ethambutol was detected in 0.7% (n = 1) and reistance to ethionamide and fluoroquinolone (FQ) in 1.3% (n = 2), while a single (0.7%) multidrug-resistant (MDR) strain was identified. SNP-based typing classified all isolates into M.tb Lineage 4, with high proportion of sublineages LAM (60.3%), T (16.4%) and Haarlem (7.9%). The average core-genome distance between isolates was 420.3 SNPs, with 43.7% of all isolates grouped across 22 genomic clusters thereby showing the presence of important ongoing TB transmission events. Most clusters were geographically distributed across the study setting which highlights the need for an urgent interruption of these large transmission chains. The data conveyed by this study shows the presence of important and uncontrolled TB transmission in the metropolitan area and provides precise data to support TB control measures in this region.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Universidade Federal do Rio de Janeiro (UFRJ), Programa Acadêmico de Tuberculose da Faculdade de Medicina e Complexo Hospitalar HUCFF-IDT, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X); Universidade Federal de Santa Catarina (UFSC), Laboratório de Biologia Molecular, Microbiologia e Sorologia, Centro de Ciências da Saúde, Florianópolis, Brazil (GRID:grid.411237.2) (ISNI:0000 0001 2188 7235)
2 Universidade Federal de Santa Catarina (UFSC), Laboratório de Biologia Molecular, Microbiologia e Sorologia, Centro de Ciências da Saúde, Florianópolis, Brazil (GRID:grid.411237.2) (ISNI:0000 0001 2188 7235)
3 Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pós-graduação em Biologia Celular e Molecular, Porto Alegre, Brazil (GRID:grid.8532.c) (ISNI:0000 0001 2200 7498); Centro Estadual de Vigilância em Saúde, Secretaria Estadual da Saúde do Rio Grande do Sul, Centro de Desenvolvimento Científico e Tecnológico (CDCT), Porto Alegre, Brazil (GRID:grid.8532.c)
4 Laboratório Central do Estado de Santa Catarina (LACEN-SC), Setor de Bacteriologia da Tuberculose, Florianópolis, Brazil (GRID:grid.411237.2)
5 Universidade de Lisboa, iMed.Ulisboa-Research Institute for Medicines, Faculdade de Farmácia, Lisboa, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263)
6 Universidade Nova de Lisboa, Unidade de Microbiologia Médica, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Lisboa, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713)
7 Universidade Federal do Rio de Janeiro (UFRJ), Programa Acadêmico de Tuberculose da Faculdade de Medicina e Complexo Hospitalar HUCFF-IDT, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X)